These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 216130
1. Cyclic nucleotides in platelet function. Haslam RJ, Davidson MM, Fox JE, Lynham JA. Thromb Haemost; 1978 Oct 31; 40(2):232-40. PubMed ID: 216130 [Abstract] [Full Text] [Related]
2. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH, Haslam RJ. Mol Pharmacol; 1990 May 31; 37(5):671-81. PubMed ID: 2160060 [Abstract] [Full Text] [Related]
3. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2. Miller OV, Gorman RR. J Cyclic Nucleotide Res; 1976 May 31; 2(2):79-87. PubMed ID: 177467 [Abstract] [Full Text] [Related]
4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi M, Zahavi J, Kakkar VV. Thromb Haemost; 1984 Oct 31; 52(2):205-9. PubMed ID: 6098048 [Abstract] [Full Text] [Related]
6. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor. McDonald JW, Stuart RK. J Lab Clin Med; 1974 Jul 31; 84(1):111-21. PubMed ID: 4365532 [Abstract] [Full Text] [Related]
7. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Gordge MP, Hothersall JS, Noronha-Dutra AA. Br J Pharmacol; 1998 May 31; 124(1):141-8. PubMed ID: 9630353 [Abstract] [Full Text] [Related]
8. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels. Pontecorvo EG, Myers CB, Lippton HL, Kadowitz PJ. Prostaglandins Med; 1981 May 31; 6(5):473-83. PubMed ID: 6267636 [Abstract] [Full Text] [Related]
9. Effect on platelet functions of derivatives of cyclic nucleotides. Pareti FI, Carrera D, Mannucci L, Mannucci PM. Thromb Haemost; 1978 Apr 30; 39(2):404-10. PubMed ID: 209573 [Abstract] [Full Text] [Related]
10. Regulation of blood platelet function by cyclic nucleotides. Haslam RJ, Davidson MM, Davies T, Lynham JA, McClenaghan MD. Adv Cyclic Nucleotide Res; 1978 Apr 30; 9():533-52. PubMed ID: 208396 [No Abstract] [Full Text] [Related]
11. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ. J Cyclic Nucleotide Res; 1979 Apr 30; 5(2):125-34. PubMed ID: 221552 [Abstract] [Full Text] [Related]
16. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation. Hagiwara M, Endo T, Kanayama T, Hidaka H. J Pharmacol Exp Ther; 1984 Feb 30; 228(2):467-71. PubMed ID: 6141286 [Abstract] [Full Text] [Related]
17. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Ashida SI, Abiko Y. Thromb Haemost; 1979 Apr 23; 41(2):436-49. PubMed ID: 224522 [Abstract] [Full Text] [Related]